Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Clinical Research Standardized Reading Procedures iRECIST RECIST Research with mint mintLesion

Related Resources

Related Resources

Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imaging

In the first week of March, we will make the relevant software functions available for all our current users at no cost. We plan to offer the COVID-19…

Clear, consistent, and complete documentation of imaging-derived information

The radiology report is expected to provide information that impacts life changing treatment decisions at every cancer care step in which imaging is…

Improving interdisciplinary communication when using PI-RADS v2.1

Dr. Robert McFarland shares his experience of using mint Lesion™ at his radiology practice in this brief interview. He talks about the challenges of…